Selected article for: "SARS CoV spike protein and spike protein"

Author: Samuel J. S. Rubin; Samuel Robert Falkson; Nicholas Degner; Catherine Blish
Title: Clinical characteristics associated with COVID-19 severity in California
  • Document date: 2020_3_30
  • ID: as6tbfrh_14
    Snippet: The potential role of the RAAS system in COVID-19 pathogenesis stems from mounting sequence and structural evidence indicating entry of SARS-CoV-2 via interaction of its spike protein with its human host receptor angiotensin-converting enzyme 2 (ACE2) (5). It is difficult to predict the effects of RAAS blockade in treatment of COVID-19, as it may increase expression of ACE2, with known anti-inflammatory and pulmonary protective properties, yet si.....
    Document: The potential role of the RAAS system in COVID-19 pathogenesis stems from mounting sequence and structural evidence indicating entry of SARS-CoV-2 via interaction of its spike protein with its human host receptor angiotensin-converting enzyme 2 (ACE2) (5). It is difficult to predict the effects of RAAS blockade in treatment of COVID-19, as it may increase expression of ACE2, with known anti-inflammatory and pulmonary protective properties, yet simultaneously promote viral entry (6). However, RAAS blockade may also increase soluble ACE2, which could serve as a decoy receptor protecting against viral entry.

    Search related documents:
    Co phrase search for related documents
    • angiotensin convert and human host receptor: 1
    • angiotensin convert and SARS entry: 1
    • angiotensin convert and spike protein: 1
    • angiotensin convert enzyme and human host: 1
    • angiotensin convert enzyme and human host receptor: 1
    • decoy receptor and human host: 1, 2
    • decoy receptor and human host receptor: 1, 2
    • decoy receptor and SARS entry: 1, 2
    • decoy receptor and spike protein: 1, 2, 3, 4, 5, 6, 7, 8
    • human host and pathogenesis stem: 1
    • human host and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • human host and RAAS system: 1
    • human host and SARS entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human host and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human host and structural evidence: 1
    • human host receptor and potential role: 1, 2, 3, 4
    • human host receptor and SARS entry: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • human host receptor and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human host receptor spike protein and spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18